AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naruszewicz, M.
Right arrow Articles by Bukowska, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naruszewicz, M.
Right arrow Articles by Bukowska, H.
Agricola
Right arrow Articles by Naruszewicz, M.
Right arrow Articles by Bukowska, H.
American Journal of Clinical Nutrition, Vol. 76, No. 6, 1249-1255, December 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers1,2,3

Marek Naruszewicz, Marie-Louise Johansson, Danuta Zapolska-Downar and Hanna Bukowska

1 From the Regional Center for Atherosclerosis Research, Pomeranian Academy of Medicine, Szczecin, Polan (MN, DZ-D, and HB), and Probi AB, Lund, Sweden (M-LJ).

Background: The short-chain fatty acids formed in the human colon by the bacterial fermentation of fiber may have an antiinflammatory effect, may reduce insulin production, and may improve lipid metabolism. We previously showed in hypercholesterolemic patients that supplementation with the probiotic bacteria Lactobacillus plantarum 299v significantly lowers concentrations of LDL cholesterol and fibrinogen.

Objective: We determined the influence of a functional food product containing L. plantarum 299v on lipid profiles, inflammatory markers, and monocyte function in heavy smokers.

Design: Thirty-six healthy volunteers (18 women and 18 men) aged 35–45 y participated in a controlled, randomized, double-blind trial. The experimental group drank 400 mL/d of a rose-hip drink containing L. plantarum 299v (5 x 107 colony-forming units/mL); the control group consumed the same volume of product without bacteria. The experiment lasted 6 wk and entailed no changes in lifestyle.

Results: Significant decreases in systolic blood pressure (P < 0.000), leptin (P < 0.000), and fibrinogen (P < 0.001) were recorded in the experimental group. No such changes were observed in the control group. Decreases in F2-isoprostanes (37%) and interleukin 6 (42%) were also noted in the experimental group in comparison with baseline. Monocytes isolated from subjects treated with L. plantarum showed significantly reduced adhesion (P < 0.001) to native and stimulated human umbilical vein endothelial cells.

Conclusion: L. plantarum administration leads to a reduction in cardiovascular disease risk factors and could be useful as a protective agent in the primary prevention of atherosclerosis in smokers.

Key Words: Probiotic bacteria • Lactobacillus plantarum • systolic blood pressure • leptin • fibrinogen • oxidative stress • cardiovascular disease • smokers




This article has been cited by other articles:


Home page
Nutr Clin PractHome page
S. Bengmark and R. Martindale
Prebiotics and Synbiotics in Clinical Medicine
Nutr Clin Pract, April 1, 2005; 20(2): 244 - 261.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition